Kamal Niaz

Dr. Kamal Niaz

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Ageing Research Reviews
Verified
Journal Article
Closed access
MRMahban Rahimifard
Mahban Rahimifard
FMFaheem Maqbool
Faheem Maqbool
SMShermineh Moeini-Nodeh
Shermineh Moeini-Nodeh
KNKamal Niaz
Kamal Niaz
MAMohammad Abdollahi
Mohammad Abdollahi
SNSeyed Fazel Nabavi
Seyed Fazel Nabavi

19 August 2015
Verified
Journal Article
Open access
HBHaji Bahadar
Haji Bahadar
FMFaheem Maqbool
Faheem Maqbool
KNKamal Niaz
Kamal Niaz
MAMohammad Abdollahi
Mohammad Abdollahi
Nanotechnology is a rapidly growing field having potential applications in many areas. Nanoparticles (NPs) have been studied for cell toxicity, immunotoxicity, and genotoxicity. Tetrazolium-based assays such as MTT, MTS, and WST-1 are used to determine cell viability. Cell inflammatory response induced by NPs is checked by measuring inflammatory biomarkers, such as IL-8, IL-6, and tumor necrosis factor, using ELISA. Lactate dehydrogenase (LDH) assay is used for cell membrane integrity. Different types of cell cultures, including cancer cell lines have been employed as in vitro toxicity models. It has been generally agreed that NPs interfere with either assay materials or with detection systems. So far, toxicity data generated by employing such models are conflicting and inconsistent. Therefore, on the basis of available experimental models, it may be difficult to judge and list some of the more valuable NPs as more toxic to biological systems and vice versa. Considering the potential applications of NPs in many fields and the growing apprehensions of FDA about the toxic potential of nanoproducts, it is the need of the hour to look for new internationally agreed free of bias toxicological models by focusing more on in vivo studies.

1 May 2019 in Life Sciences
Verified
Journal Article
Closed access
EZElizabeta Zaplatic
Elizabeta Zaplatic
MBMuhammed Bule
Muhammed Bule
SSSyed Zahid Ali Shah
Syed Zahid Ali Shah
SUSahab Uddin
Sahab Uddin
KNKamal Niaz
Kamal Niaz

29 August 2016 in Nutrients
Verified
Journal Article
Open access
PDF file
Fazlullah KhanFazlullah Khan
Fazlullah Khan
KNKamal Niaz
Kamal Niaz
FMFAHEEM MAQBOOL
FAHEEM MAQBOOL
FHFatima Ismail Hassan
Fatima Ismail Hassan
MAMohammad Abdollahi
Mohammad Abdollahi
Anupam BishayeeAnupam Bishayee
Anupam Bishayee
Quercetin, a medicinally important member of the flavonoid family, is one of the most prominent dietary antioxidants. It is present in a variety of foods—including fruits, vegetables, tea, wine, as well as other dietary supplements—and is responsible for various health benefits. Numerous pharmacological effects of quercetin include protection against diseases, such as osteoporosis, certain forms of malignant tumors, and pulmonary and cardiovascular disorders. Quercetin has the special ability of scavenging highly reactive species, such as hydrogen peroxide, superoxide anion, and hydroxyl radicals. These oxygen radicals are called reactive oxygen species, which can cause oxidative damage to cellular components, such as proteins, lipids, and deoxyribonucleic acid. Various oxygen radicals play important roles in pathophysiological and degenerative processes, such as aging. Subsequently, several studies have been performed to evaluate possible advantageous health effects of quercetin and to collect scientific evidence for these beneficial health claims. These studies also gather data in order to evaluate the exact mechanism(s) of action and toxicological effects of quercetin. The purpose of this review is to present and critically analyze molecular pathways underlying the anticancer effects of quercetin. Current limitations and future directions of research on this bioactive dietary polyphenol are also critically discussed.

9 March 2017 in Epidemiology and Health
Verified
Journal Article
Open access
PDF file
KNKamal Niaz
Kamal Niaz
FMFaheem Maqbool
Faheem Maqbool
Fazlullah KhanFazlullah Khan
Fazlullah Khan
HBHaji Bahadar
Haji Bahadar
FHFatima Ismail Hassan
Fatima Ismail Hassan
MAMohammad Abdollahi
Mohammad Abdollahi
Smokeless tobacco consumption, which is widespread throughout the world, leads to oral submucous fibrosis (OSMF), which is a long-lasting and devastating condition of the oral cavity with the potential for malignancy. In this review, we mainly focus on the consumption of smokeless tobacco, such as paan and gutkha, and the role of these substances in the induction of OSMF and ultimately oral cancer. The list of articles to be examined was established using citation discovery tools provided by PubMed, Scopus, and Google Scholar. The continuous chewing of paan and swallowing of gutkha trigger progressive fibrosis in submucosal tissue. Generally, OSMF occurs due to multiple risk factors, especially smokeless tobacco and its components, such as betel quid, areca nuts, and slaked lime, which are used in paan and gutkha. The incidence of oral cancer is higher in women than in men in South Asian countries. Human oral epithelium cells experience carcinogenic and genotoxic effects from the slaked lime present in the betel quid, with or without areca nut. Products such as 3-(methylnitrosamino)-proprionitrile, nitrosamines, and nicotine initiate the production of reactive oxygen species in smokeless tobacco, eventually leading to fibroblast, DNA, and RNA damage with carcinogenic effects in the mouth of tobacco consumers. The metabolic activation of nitrosamine in tobacco by cytochrome P450 enzymes may lead to the formation of N-nitrosonornicotine, a major carcinogen, and micronuclei, which are an indicator of genotoxicity. These effects lead to further DNA damage and, eventually, oral cancer.

1 July 2020 in Ageing Research Reviews
Verified
Journal Article
Closed access
SUSahab Uddin
Sahab Uddin
DTDevesh Tewari
Devesh Tewari
AMAbdullah Al Mamun
Abdullah Al Mamun
TKTanvir Kabir
Tanvir Kabir
KNKamal Niaz
Kamal Niaz
Ghulam M. AshrafGhulam M. Ashraf
Ghulam M. Ashraf